• OPEN AN ACCOUNT
Indian Indices
Nifty
24,973.10 104.50
(0.42%)
Sensex
81,425.15 323.83
( 0.40%)
Bank Nifty
54,536.00 319.90
( 0.59%)
Nifty IT
36,183.80 927.90
( 2.63%)
Global Indices
Nasdaq
45,729.90 193.94
(0.43%)
Dow Jones
6,533.40 17.25
(0.26%)
Hang Seng
43,788.68 329.39
(0.76%)
Nikkei 225
9,225.39 -17.14
(-0.19%)
Forex
USD-INR
88.02 -0.16
(-0.18%)
EUR-INR
103.30 -0.01
(-0.01%)
GBP-INR
119.05 -0.02
(-0.01%)
JPY-INR
0.60 0.00
(-0.34%)

EQUITY - MARKET SCREENER

Par Drugs & Chemicals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
535341
INE04LG01015
80.4368662
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
PAR
9.4
133.01
EPS(TTM)
Face Value()
Div & Yield %
11.5
10
0
 

reliance infrastructure ltd
Jindal Saw Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Aug 06,2025
This is with reference to the captioned subject and our letter dated August 01 2025 ICICI Securities Limited had organized a conference call for analyst and investors on the Unaudited (Standalone & Consolidated) financial results (Q1FY26) of the Company for the quarter ended June 30 2025 on Wednesday August 06 2025 at 15:00 Hrs IST. The audio recording of the conference call has been made available on the website of the Company at https://www.jindalsaw.com/audio/Jindal%20Saw%20-%20Q1%20FY26%20Audio%20Recording.mp3